DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Actinium Pharma Reports First Patient Treated In Third, Final Dose Cohort Of Actimab-A CLAG-M Combo Phase 1 Trial In ACute Myeloid Leukemia

Benzinga · 03/05/2020 12:40